Gram Negative Super Bugs: A New Generation of ICU Infections, an Emerging Challenge for Health Care Settings

Vaibhavi Subhedar^1, and Sudhir Kumar Jain²

¹Consultant Microbiologist and Infection Control Incharge Bombay Hospital Indore MP India, PH.D Scholar in Microbiology Vikram University Ujjain MP India

²Reader School of Studies in Microbiology Vikram University Ujjain MP India

Cite this paper:
Vaibhavi Subhedar and Sudhir Kumar Jain. Gram Negative Super Bugs: A New Generation of ICU Infections, an Emerging Challenge for Health Care Settings. American Journal of Microbiological Research. 2016; 4(1):47-50. doi: 10.12691/ajmr-4-1-6

Abstract

Emergence of Antimicrobial resistance is a growing threat worldwide, and a major threat in India where antibiotics are readily available. The patients in Intensive care units are at 5 to 10 times more risk of acquiring hospital acquired infections due to various multi drug resistant bacterias. Gram Negative bugs are most observed in Indian ICUs, which is a major challenge for the intensivists in their clinical practice. The major mechanism of resistance in these Gram negative bacteria are the enzymes called Beta lactamases like ESBL, AmpC, and carbapenemases. The present study was undertaken to determine the spectrum of Multidrug resistant Gram negative bacteria causing infections in the ICUs and the common beta lactamases acquired by them, which were detected phenotypically and genotypically by Multiplex PCR. These findings will guide the clinicians in appropriate empirical therapy, reduce drug resistance and thus improve patient outcome.

Keywords:
antimicrobial resistance beta lactamases intensive care units gram negative bacteria

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Amudhan SM, Sekar U, Arunagiri K, Sekar B (2008). OXA beta lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian Journal of Medical Microbiology; 127:269-274.
[2]	Afzal Azim, Mayank Dwivedi, P.Bhaskar Rao, A.K. Baronia, R.K. Singh (2010); Epidemiology of bacterial colonization at ICU admission with emphasis on ESBL and MBL producing GNB- an Indian experience. J. of Med. Microbiology; 59:955-960.
[3]	Anand Manoharan, Madhan Sugumar, Anil Kumar and Hepzibah (2012). Phenotypic and molecular characterization of AmpC beta lactamases among E.coli, Klebsiella spp and Enteobacter spp. from 5 Indian Medical centers Jose (ICMR-ESBL study group); Indian J Med Res 135:359-364.
[4]	Canton R, Akova M, Carmell Y, Giske CG, Glupczynski Y, (2012). Rapid evolution and spread of carbpenemases among Enterobacteriaceae in Europe. Clinical Microbiology Infections.; 18:413-431.
[5]	Carlos M. Luna, Eduardo Rodriguez-Noriega, Luis Bavestrello and Manuel-Guzman-Blanco (2014). Gram-Negative Infections in adult ICUs of Latin America and the Carribean. Critical Care research and Practice; 2014:1-12.
[6]	Gupta V, Datta P, Chander J (2006). Prevalence of metallo β- lactamases (MBL) producing Pseudomonas and Acinetobacter spp in a tertiary care hospital in India. J Infect ; 52 : 311-4.
[7]	Jacoby GA (2009). AmpC beta lactamases. Clinical Microbiology Review. ; 22:161-182.
[8]	Bush Karen (2010). Bench-to-bedside review: The role of beta lactamases in antibiotic resistant Gram negative infections. Critical Care ; 14:224-236.
[9]	Thirapanmethee K. (2012). Extended Spectrum Beta lactamases: Critical tools of Bacterial Resistance. Mahidol University Journal of Pharmaceutical Science.;39(1):1-8.
[10]	Oberoi Loveen, Nachhatarjit singh, Poonam Sharma, Aruna Aggarwal (2013) ESBL, MBL and AmpC betalactamases Producing Superbugs-Havoc in the Intensive Care Units of Punjab India. Journal of Clinical and diagnostic Reseach;7(1):70-73.
[11]	Chaudhary Manu, Anurag Payasi (2013). Incidence, prevalence and control of MDR carbapenemase producing Acinetobacter baumanii in Indian ICUs. Journal of Pharmacy Res: 1-6.
[12]	Mita D. Wadekar, K. Anuradha and D. Venkatesha. (2013). Phenotypic detection of ESBL and MBL in clinical isolates of Enterobacteriaceae. Int J of Current Res and Academic Review; 1(3):89-95.
[13]	Brusselaers Nele, Dirk Vogelaers and Stijn Blot (2011). The rising problem of antimicrobial resistance in the intensive care unit. Annals of Intensive Care; 1:47-57.
[14]	Nordmann P, Cuzon G, Naas T (2009). "The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria". Lancet Infect Dis ; 9(4): 228-36.
[15]	Porwal Ravikant, Ram Gopalakrishnan, Naga Jawahar Rajesh, V Ramasubramanian. (2014). Carbapenem resistant Gram negative bacteremia in an Indian ICU: A review of the clinical profile and treatment outcome of 50 patients. Indian J. of Critical Care Medicine; 18 (11):750-753.